Urinary phytoestrogen excretion and postmenopausal breast cancer risk: The multiethnic cohort study

Cancer Prevention Research

Volumn 2, Issue 10, 2009, Pages 887-894

  Goodman, Marc T ^a   Shvetsov, Yurii B ^a   Wilkens, Lynne R ^a   Franke, Adrian A ^a   Le Marchand, Loic ^a   Kakazu, Kerry K ^a   Nomura, Abraham M Y ^a   Henderson, Brian E ^b   Kolonel, Laurence N ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUOL; GENISTEIN; ISOFLAVONE DERIVATIVE; PHYTOESTROGEN;

ADULT; AGED; ARTICLE; ASIAN AMERICAN; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; URINARY EXCRETION;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; PHYTOESTROGENS; POSTMENOPAUSE; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 70449447914     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0039     Document Type: Article

References (35)

1. Peeters PH, Keinan-Boker L, van der Schouw YT, Grobbee DE. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res Treat 2003;77:171-183
2. Murphy PA, Song T, Buseman G, et al. Isoflavones in retail and institutional soy foods. J Agric Food Chem 1999;47:2697-2704 (Pubitemid 29396341)
3. Thompson LU, Robb P, Serraino M, Cheung F. Mammalian lignan production from various foods. Nutr Cancer 1991;16:43-52.
4. Valentin-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB. Urinary phytoestrogen concentrations in the U.S. population (1999-2000). J Expo Anal Environ Epidemiol 2005;15:509-523
5. Lampe JW, Karr SC, Hutchins AM, Slavin JL. Urinary equol excretion with a soy challenge: influence of habitual diet. Proc Soc Exp Biol Med 1998;217:335-339
6. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol 2002;3:364-373
7. Adlercreutz H. Phytoestrogens and breast cancer. J Steroid Biochem Mol Biol 2002;83:113-118
8. Mai Z, Blackburn GL, Zhou JR. Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells. Mol Carcinog 2007;46:534-542
9. Thompson LU, Chen JM, Li T, Strasser-Weippl K, Goss PE. Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. Clin Cancer Res 2005;11:3828-3835 (Pubitemid 40685603)
10. Track BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst 2006;98:459-471
11. Ziegler RG, Hoover RN, Pike MC, et al. Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 1993;85:1819-1827 (Pubitemid 23333614)
12. Cancer incidence in five continents. In: Curado MP, Edwards B, Shin HR, et al, editors. Vol.IX IARC Scientific Publications No. 160. Lyon (France): IARC; 2007.
13. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer 2008;98:9-14.
14. Boccardo F, Puntoni M, Guglielmini P, Rubagotti A. Enterolactone as a risk factor for breast cancer: a review of the published evidence. Clin Chim Acta 2006;365:58-67.
15. Touillaud MS, Thiébaut AC, Fournier A, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. Dietary lignan intake and postmenopausal breast cancer risk by estrogen and progesterone receptor status. J Natl Cancer Inst 2007;99:475-486 (Pubitemid 47078736)
16. Touillaud MS, Thiébaut AC, Niravong M, Boutron-Ruault MC, Clavel-Chapelon F. No association between dietary phytoestrogens and risk of premenopausal breast cancer in a French cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:2574-2576
17. den Tonkelaar I, Keinan-Boker L, Veer PV, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001;10:223-228
18. Hultén K, Winkvist A, Lenner P, Johansson R, Adlercreutz H, Hallmans G. An incident case-referent study on plasma enterolactone and breast cancer risk. Eur J Nutr 2002;41:168-176 (Pubitemid 36056326)
19. Olsen A, Knudsen KE, Thomsen BL, et al. Plasma enterolactone and breast cancer incidence by estrogen receptor status. Cancer Epidemiol Biomarkers Prev 2004;13:2084-2089 (Pubitemid 40054302)
20. Zeleniuch-Jacquotte A, Adlercreutz H, Shore RE, et al. Circulating enterolactone and risk of breast cancer: a prospective study in New York. Br J Cancer 2004;91:99-105. (Pubitemid 39013052)
21. Kilkkinen A, Virtamo J, Vartiainen E, et al. Serum enterolactone concentration is not associated with breast cancer risk in a nested case-control study. Int J Cancer 2004;108:277-280 (Pubitemid 37541783)
22. Grace PB, Taylor JI, Low YL, et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 2004;13:698-708.
23. Verheus M, van Gils CH, Keinan-Boker L, Grace PB, Bingham SA, Peeters PH. Plasma phytoestrogens and subsequent breast cancer risk. J Clin Oncol 2007;25:648-655
24. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res 2008;10:R32.
25. Iwasaki M, Inoue M, Otani T, et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group. J Clin Oncol 2008;26:1677-1683
26. Kolonel LN, Henderson BE, Hankin JH, et al. A multiethnic cohort in Hawaii and Los Angeles: baseline characteristics. Am J Epidemiol 2000;151:346-357
27. Ries LAG, Melbert D, Krapcho M, et al, editors. SEER Cancer Statistics Review, 1975-2005. Bethesda (MD): National Cancer Institute; 2008. Available from: http://seer.cancer.gov/csr/1975-2005/.
28. Franke AA, Custer LJ, Wilkens LR, et al. Liquid chromatographic- photodiode array mass spectrametric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci 2002;777:45-59.
29. Maskarinec G, Hebshi S, Custer L, Franke AA. The relation of soy intake and isoflavone levels in nipple aspirate fluid. Eur J Cancer Prev 2008;17:67-70.
30. Franke AA, Custer LJ, Wang W, Shi CY. HPLC analysis of isoflavonoids and other phenolic agents from foods and from human fluids. Proc Soc Exp Biol Med 1998;217:263-273 (Pubitemid 28130672)
31. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. (IARC Scientific Publication no. 32). Lyon (France): International Agency for Research on Cancer; 1980.
32. Setchell KD, Cole SJ. Method of defining equolpraducer status and its frequency among vegetarians. J Nutr 2006;8:2188-2193
33. Foster G, Goldsmith CH. Problems commonly associated with forest plots addressed using high resolution graphics in SAS (Paper 139-31). San Francisco (CA): SAS Users Group International 31 Proceedings; 2006.
34. Franke AA, Yu MC, Maskarinec G, Fanti P, Zheng W, Custer LJ. Phytoestrogens in human biomatrices including breast milk. Biochem Soc Trans 1999;27:308-318 (Pubitemid 29086055)
35. Franke AA, Halm BM, Ashburn LA. Isoflavones in children and adults consuming soy. Arch Biochem Biophys 2008;476:161-170